Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomography

[1]  S. Basu,et al.  Uptake characteristics of FDG in multiple juvenile cellular fibroadenomata of the breast: FDG-PET and histopathologic correlation. , 2007, Clinical nuclear medicine.

[2]  H. Nabi,et al.  18F-FDG imaging: pitfalls and artifacts. , 2005, Journal of nuclear medicine technology.

[3]  P. Mikosch,et al.  Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions. , 2003, Breast.

[4]  M. Schwaiger,et al.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Michell,et al.  MP44-04 IMPORTANCE OF THE ULTRASOUND CHARACTERISTICS OF REGIONS OF INTEREST BY MRI AND THE ADDITIONAL TARGET BIOPSY AROUND THEIR PERI-HYPOECHOIC LESIONS IN MR/TRUS SOFTWARE FUSION BIOPSY TO IMPROVE DETECTION RATE OF PROSTATE CANCER , 2023, Journal of Urology.

[6]  H. Biersack,et al.  Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours , 1997, European Journal of Nuclear Medicine.

[7]  M Schwaiger,et al.  Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Salm,et al.  Ductal adenoma of the breast: A lesion which can mimic carcinoma , 1984, The Journal of pathology.

[9]  F. Akiyama,et al.  Clinical and Pathologic Features of Fibroadenoma of the Mastopathic Type , 2006, Surgery Today.